Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Allergy & Immunology
Cyclophosphamide
Questions discussed in this category
Which ANCA vasculitis patients are better candidates for cyclophosphamide rather than rituximab?
2 Answers available
7314
Papers discussed in this category
The New England journal of medicine, 2010-07-15
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
Medicine (Baltimore),
The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.
The New England journal of medicine, 2010-07-15
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
Related Topics in Allergy & Immunology
Breast Cancer
Hematologic Malignancies
Radiation Oncology
Pediatric Hematology/Oncology
Medical Oncology
Bone Marrow Transplant
Biologic Therapy/Immunobiology
Internal Medicine
Rheumatology
ALL
